Biotech companies - researching immunotherapies , particularly in combination therapy , it’s just a very slow Path.
Changes in tack required often along the pathway .
Leslie Chong is a highly credentialed, intelligent & genuine leader , I think .
She is usually willing to spend the time explaining scientific basis of the trials and past findings to shareholders , or people with questions , whenever she is available .
Have enormous respect for her .
Wow - that she came out to Australia , to join Imugene .
She will never give up , is my impression of her from over several years now .
In the news -for information all .
Is tough going for immunotherapy based, small -cap biotech researchers.
(though the work they’re doing is considered to be vitally important . ) Be fantastic, excellent - if Imugene immunotherapy for no- hope and more dire cancer prognosis sufferers gains success :
https://investingnews.com/daily/lif...n-state-future-immunotherapies/?mqsc=E4024631
Charting Only., page-217
-
- There are more pages in this discussion • 2,309 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1854997 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 382882 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |